Pathophysiological Rationale and Clinical Evidence for Neurohormonal Modulation in Heart Failure with Preserved Ejection Fraction
Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome resulting from the interaction between cardiac diseases, comorbidities and ageing. HFpEF is characterised by the activation of neurohormonal axes, namely of the renin-angiotensin-aldosterone system and the sympathetic...
Saved in:
| Main Authors: | Vincenzo Castiglione, Francesco Gentile, Nicolò Ghionzoli, Martina Chiriacò, Giorgia Panichella, Alberto Aimo, Giuseppe Vergaro, Alberto Giannoni, Claudio Passino, Michele Emdin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2023-06-01
|
| Series: | Cardiac Failure Review |
| Online Access: | https://www.cfrjournal.com/articleindex/cfr.2022.23 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Eligibility for vericiguat in a real‐world, contemporary heart failure population
by: Giuseppe Vergaro, et al.
Published: (2024-12-01) -
Neurohormonal activation pattern in patients with atrial septal defect
by: Rengin Çetin Güvenç, et al.
Published: (2024-12-01) -
Heart failure with preserved ejection fraction (HFpEF) pathophysiology study (IDENTIFY-HF): does increased arterial stiffness associate with HFpEF, in addition to ageing and vascular effects of comorbidities? Rationale and design
by: Prithwish Banerjee, et al.
Published: (2019-11-01) -
Rationale and design of the preserved versus reduced ejection fraction biomarker registry and precision medicine database for ambulatory patients with heart failure (PREFER-HF) study
by: James L Januzzi, et al.
Published: (2021-12-01) -
Glucagon-like Peptide-1 Receptor Agonists in the Context of Pathophysiology of Diverse Heart Failure with Preserved Ejection Fraction Phenotypes: Potential Benefits and Mechanisms of Action
by: Aleksandra Bykova, et al.
Published: (2024-10-01)